has landed a contract with GlaxoSmithKline to provide the pharmaceutical giant with microarray-based genotyping services. Other WRAL Top Stories Microarray technology enables researchers to genetic ...
This Research Topic is part of the article collection series -<a href=" Plant Genotyping: From Traditional Markers to Modern ...
Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...
To map most of the genetic variation in the human genome, scientists need to look at several hundred thousand single nucleotide polymorphisms (SNPs) per individual. Most genotyping assays employ ...
Join us for an insightful webinar on the use of polygenic risk scores (PRS) for cardiovascular disease (CVD). The analysis of genetic variation across large populations plays a crucial role in ...
The past decade has seen accelerated discovery of the causal genes underlying Mendelian and complex diseases as well as progress toward the goal of personalized medicine. Technological achievements ...
SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback